Winthrop Advisory Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$446K Buy
4,307
+208
+5% +$18.6K 0.03% 134
2026
Q1
$294K Sell
4,099
-6
-0.1% -$462 0.02% 142
2025
Q4
$326K Sell
4,105
-13
-0.3% -$1.02K 0.03% 132
2025
Q3
$310K Buy
+4,118
New +$282K 0.03% 134
2025
Q2
– Sell
-3,235
Closed -$219K – 184
2025
Q1
$219K Buy
+3,235
New +$194K 0.03% 140
2024
Q4
– Sell
-3,366
Closed -$212K – 160
2024
Q3
$212K Buy
+3,366
New +$196K 0.03% 141
2024
Q2
– Sell
-3,894
Closed -$311K – 148
2024
Q1
$311K Buy
3,894
+11
+0.3% +$840 0.04% 112
2023
Q4
$307K Buy
3,883
+49
+1% +$3.49K 0.05% 102
2023
Q3
$268K Sell
3,834
-29
-0.8% -$2.06K 0.04% 100
2023
Q2
$267K Buy
3,863
+1
+0% +$71 0.04% 110
2023
Q1
$287K Sell
3,862
-557
-13% -$46.7K 0.05% 101
2022
Q4
$412K Buy
4,419
+352
+9% +$34K 0.08% 80
2022
Q3
$388K Sell
4,067
-8
-0.2% -$792 0.08% 68
2022
Q2
$378K Sell
4,075
-3
-0.1% -$293 0.09% 74
2022
Q1
$413K Buy
4,078
+623
+18% +$65.4K 0.09% 80
2021
Q4
$356K Buy
3,455
+24
+0.7% +$2.22K 0.07% 89
2021
Q3
$291K Buy
3,431
+7
+0.2% +$586 0.06% 101
2021
Q2
$286K Buy
3,424
+6
+0.2% +$491 0.06% 101
2021
Q1
$257K Sell
3,418
-348
-9% -$25.3K 0.06% 107
2020
Q4
$257K Buy
+3,766
New +$245K 0.07% 103

Other funds holding CVS

Winthrop Advisory Group's CVS Position: Q2 2026 in Review

Winthrop Advisory Group increased its CVS Health (CVS) stake by 5.1% in Q2 2026, buying an estimated $18.6K and bringing the position to 4,307 shares worth $446K. The position accounts for 0.03% of the portfolio, ranked #134.

Winthrop Advisory Group first reported a position in CVS in Q4 2020 and has held it in 20 quarters since. 2,075 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Winthrop Advisory Group held 4,307 shares of CVS Health worth $446K as of Q2 2026.
  • Winthrop Advisory Group bought 208 CVS Health shares in Q2 2026, an estimated $18.6K.
  • CVS Health made up 0.03% of Winthrop Advisory Group's portfolio in Q2 2026, its #134 holding.
  • Winthrop Advisory Group first reported a position in CVS Health in Q4 2020 and has held it in 20 quarters since.
  • 2,075 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Winthrop Advisory Group's 13F filing for Q2 2026, filed 17 Jul 2026.